Pharvaris N.V. Gains 27.76%
Mon, Jun 26, 2023 at 07:38 PM
Pharvaris N.V. (PHVS:NASDAQ) soared at $14.82, representing a gain of 27.8%. On Mon, Jun 26, 2023, PHVS:NASDAQ hit a New 2-Week High of $14.82. The stock appeared on our News Catalysts scanner on Mon, Jun 26, 2023 at 04:57 PM in the 'BIOTECH' category. From Mon, Jun 12, 2023, the stock recorded 66.67% Up Days and 80.00% Green Days
About Pharvaris N.V. (PHVS:NASDAQ)
Pharvaris NV is a clinical-stage company.
Top 10 Gainers:
- Trxade Group, Inc. (MEDS:NASDAQ), 93.84%
- Benitec Biopharma Inc. (BNTC:NASDAQ), 81.36%
- MoonLake Immunotherapeutics Com (MLTX:NASDAQ), 77.55%
- Spark Networks SE (LOV:NASDAQ), 50.04%
- iMedia Brands, Inc. (IMBI:NASDAQ), 35.71%
- ACELYRIN INC. (SLRN:NASDAQ), 35.41%
- Shengfeng Development Limited (SFWL:NASDAQ), 33.2%
- Adagene Inc. (ADAG:NASDAQ), 30.37%
- Chemomab Therapeutics Ltd. (CMMB:NASDAQ), 28%
- Pharvaris N.V. (PHVS:NASDAQ), 27.76%